South Korea · Delayed Price · Currency is KRW Daewon Pharmaceutical Company Description
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use.
The company’s principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease.
It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa.
The company was founded in 1958 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1958 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,283 |
| CEO | Seung-Ryel Baek |
Contact Details
Address: 386 Cheonhodae-ro Seoul South Korea | |
| Phone | 82 2 2204 7000 |
| Website | daewonpharm.com |
Stock Details
| Ticker Symbol | 003220 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7003220001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Seung-Ryel Baek | Vice Chairman, Chief Executive Officer and President |